# Regulations.gov document: Reference 5 - Malyshkina A, Solar M, Balasubramaniyan N, Zheng L, McCulley DJ, Morro M, et
al. TLR9-mediated innate immune signaling contributes to acetaminophen-induced injury
in the developing lung. Am J Physiol Lung Cell Mol Physiol. 2026;331(1):L16-L33.
doi:10.1152/ajplung.00085.2026. PMID:42155595. PMCID:PMC13273618. — retained record

> Retained regulations record from regulations-gov.

Canonical: https://highsignal.app/data/records/335db6b03140f254

[← sources](https://highsignal.app/data)

al. TLR9-mediated innate immune signaling contributes to acetaminophen-induced injury
in the developing lung. Am J Physiol Lung Cell Mol Physiol. 2026;331(1):L16-L33.
doi:10.1152/ajplung.00085.2026. PMID:42155595. PMCID:PMC13273618.

source: [regulations](https://highsignal.app/data/regulations) (regulations-gov)  published 2026-08-18 04:00 ingested 2026-08-19 06:29

[original source ↗](https://www.regulations.gov/document/FDA-2026-P-9430-0007)

## retained text



```
Query: data center
Agency: FDA
Type: Supporting & Related Material
Docket: FDA-2026-P-9430
```



document fetched 2026-08-19 06:29 · canonical https://regulations.gov/document/FDA-2026-P-9430-0007